Related references
Note: Only part of the references are listed.Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target
Silvia Giatti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Characterizing the Genomic Profile in High-Grade Gliomas: From Tumor Core to Peritumoral Brain Zone, Passing through Glioma-Derived Tumorspheres
Martina Giambra et al.
BIOLOGY-BASEL (2021)
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect
A. Malacrida et al.
SCIENTIFIC REPORTS (2021)
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Wei Wu et al.
PHARMACOLOGICAL RESEARCH (2021)
A narrative review of research progress on drug therapies for glioblastoma multiforme
Xiangjin Zheng et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
DNA direct reversal repair and alkylating agent drug resistance
Roberto Gutierrez et al.
CANCER DRUG RESISTANCE (2021)
Dissecting the mechanism of temozolomide resistance and its association with the regulatory roles of intracellular reactive oxygen species in glioblastoma
Chia-Hung Chien et al.
JOURNAL OF BIOMEDICAL SCIENCE (2021)
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line
Alessio Malacrida et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
Wei Yu et al.
FRONTIERS IN ONCOLOGY (2020)
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
Aleksandr Ianevski et al.
NUCLEIC ACIDS RESEARCH (2020)
Epigenetic regulation of DNA repair genes and implications for tumor therapy
Markus Christmann et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2019)
11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells
Tania Aguado et al.
SCIENTIFIC REPORTS (2019)
Dual or multi-targeting inhibitors: The next generation anticancer agents
Nulgumnalli Manjunathaiah Raghavendra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Outlining involvement of stem cell program in regulation of O6-methylguanine DNA methyltransferase and development of temozolomide resistance in glioblastoma: An Editorial Highlight for 'Transcriptional control of O6-methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma' on page 780
Anastasia Chumakova et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Transcriptional control of O6-methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma
Caroline Happold et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014
Quinn T. Ostrom et al.
JAMA ONCOLOGY (2018)
SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017)
M. Martinez-Garcia et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression
Fengming Lan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
DNA repair mechanisms and their clinical impact in glioblastoma
Helene Erasimus et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2016)
Origin of the U87MG glioma cell line: Good news and bad news
Marie Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review)
Giulio Cabrini et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
SPILLO-PBSS: Detecting Hidden Binding Sites within Protein 3D-Structures Through a Flexible Structure-Based Approach
Alessandro Di Domizio et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells
Tor-Christian Aase Johannessen et al.
NEURO-ONCOLOGY (2013)
Delineating the Cytogenomic and Epigenomic Landscapes of Glioma Stem Cell Lines
Simona Baronchelli et al.
PLOS ONE (2013)
STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression
Shinji Kohsaka et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Primary brain tumours in adults
Damien Ricard et al.
LANCET (2012)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Microwave Assisted Efficient Synthesis of Imidazole-Based Privileged Structures
Marco Fantini et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2010)
NMR analysis of a series of imidazobenzoxazines
Mirko Rivara et al.
MAGNETIC RESONANCE IN CHEMISTRY (2010)
Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide
George C. Bobustuc et al.
NEURO-ONCOLOGY (2010)
Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre study
Bruno M. Costa et al.
ONCOLOGY REPORTS (2010)
Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma
Francesca Pistollato et al.
STEM CELLS (2010)
Phase 1 Trial of Temozolomide Plus Irinotecan Plus O6-Benzylguanine in Adults With Recurrent Malignant Glioma
Jennifer A. Quinn et al.
CANCER (2009)
Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
Steven M. Pollard et al.
CELL STEM CELL (2009)
Effect of IFN-β on human glioma cell lines with temozolomide resistance
Atsuo Yoshino et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapy
Ami Sabharwal et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
Jeongwu Lee et al.
CANCER CELL (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
